AUA Capital Management’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $589K | Hold |
2,709
| – | – | 0.3% | 45 |
|
|
2025
Q4 | $619K | Hold |
2,709
| – | – | 0.31% | 46 |
|
|
2025
Q3 | $627K | Hold |
2,709
| – | – | 0.35% | 43 |
|
|
2025
Q2 | $503K | Hold |
2,709
| – | – | 0.3% | 44 |
|
|
2025
Q1 | $568K | Hold |
2,709
| – | – | 0.37% | 42 |
|
|
2024
Q4 | $481K | Hold |
2,709
| – | – | 0.31% | 44 |
|
|
2024
Q3 | $535K | Sell |
2,709
-104
| -4% | -$19.4K | 0.31% | 44 |
|
|
2024
Q2 | $482K | Hold |
2,813
| – | – | 0.29% | 45 |
|
|
2024
Q1 | $512K | Buy |
2,813
+104
| +4% | +$17.9K | 0.3% | 51 |
|
|
2023
Q4 | $420K | Hold |
2,709
| – | – | 0.26% | 50 |
|
|
2023
Q3 | $404K | Buy |
2,709
+455
| +20% | +$66.8K | 0.29% | 50 |
|
|
2023
Q2 | $304K | Sell |
2,254
-750
| -25% | -$110K | 0.21% | 60 |
|
|
2023
Q1 | $479K | Hold |
3,004
| – | – | 0.32% | 45 |
|
|
2022
Q4 | $485K | Buy |
3,004
+2
| +0.1% | +$307 | 0.33% | 44 |
|
|
2022
Q3 | $403K | Sell |
3,002
-755
| -20% | -$108K | 0.27% | 46 |
|
|
2022
Q2 | $575K | Hold |
3,757
| – | – | 0.33% | 41 |
|
|
2022
Q1 | $609K | Buy |
3,757
+463
| +14% | +$67.3K | 0.33% | 40 |
|
|
2021
Q4 | $446K | Buy |
3,294
+215
| +7% | +$25.4K | 0.26% | 54 |
|
|
2021
Q3 | $332K | Hold |
3,079
| – | – | 0.21% | 59 |
|
|
2021
Q2 | $347K | Hold |
3,079
| – | – | 0.21% | 55 |
|
|
2021
Q1 | $333K | Hold |
3,079
| – | – | 0.22% | 54 |
|
|
2020
Q4 | $330K | Buy |
3,079
+5
| +0.2% | +$480 | 0.24% | 51 |
|
|
2020
Q3 | $269K | Buy |
3,074
+824
| +37% | +$77.6K | 0.22% | 51 |
|
|
2020
Q2 | $221K | Sell |
2,250
-761
| -25% | -$67K | 0.22% | 52 |
|
|
2020
Q1 | $229K | Hold |
3,011
| – | – | 0.22% | 54 |
|
|
2019
Q4 | $266K | Hold |
3,011
| – | – | 0.22% | 60 |
|
|
2019
Q3 | $228K | Hold |
3,011
| – | – | 0.18% | 70 |
|
|
2019
Q2 | $219K | Hold |
3,011
| – | – | 0.18% | 71 |
|
|
2019
Q1 | $242K | Hold |
3,011
| – | – | 0.2% | 63 |
|
|
2018
Q4 | $277K | Hold |
3,011
| – | – | 0.25% | 50 |
|
|
2018
Q3 | $285K | Hold |
3,011
| – | – | 0.23% | 59 |
|
|
2018
Q2 | $279K | Hold |
3,011
| – | – | 0.24% | 54 |
|
|
2018
Q1 | $285K | Sell |
3,011
-1
| -0% | -$110 | 0.24% | 51 |
|
|
2017
Q4 | $291K | Hold |
3,012
| – | – | 0.26% | 54 |
|
|
2017
Q3 | $268K | Hold |
3,012
| – | – | 0.25% | 57 |
|
|
2017
Q2 | $218K | Buy |
3,012
+2,250
| +295% | +$151K | 0.2% | 73 |
|
|
2017
Q1 | $50K | Sell |
762
-2,250
| -75% | -$141K | 0.05% | 101 |
|
|
2016
Q4 | $189K | Buy |
+3,012
| New | +$184K | 0.18% | 69 |
|
Other funds holding ABBV
VCM
VPM
AUA Capital Management's ABBV Position: Q1 2026 in Review
AUA Capital Management held its AbbVie (ABBV) position steady in Q1 2026 at 2,709 shares worth $589K. The position accounts for 0.3% of the portfolio, ranked #45.
AUA Capital Management first reported a position in ABBV in Q4 2016 and has held it in 38 quarters since. The position peaked at $627K in Q3 2025. 4,077 funds tracked by Wall St. Rank hold ABBV as of Q1 2026.
- AUA Capital Management held 2,709 shares of AbbVie worth $589K as of Q1 2026.
- AUA Capital Management left its AbbVie share count unchanged in Q1 2026.
- AbbVie made up 0.3% of AUA Capital Management's portfolio in Q1 2026, its #45 holding.
- AUA Capital Management first reported a position in AbbVie in Q4 2016 and has held it in 38 quarters since.
- AUA Capital Management's AbbVie position peaked at $627K in Q3 2025.
- 4,077 funds tracked by Wall St. Rank held AbbVie as of Q1 2026.
Based on AUA Capital Management's 13F filing for Q1 2026, filed 22 Apr 2026.